Human absorption of a supplement containing purified hydroxytyrosol, a natural antioxidant from olive oil, and evidence for its transient association with low-density lipoproteins

Pharmacological Research

Volumn 61, Issue 4, 2010, Pages 364-370

  González Santiago, Maria ^a   Fonollá, Juristo ^a   Lopez Huertas, Eduardo ^b  

^a Puleva Biotech SA   (Spain)

^b CSIC   (Spain)

Author keywords

Absorption; Antioxidants; Hydroxytyrosol; LDL; Olive oil polyphenols

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; GLUCURONIDE; HOMOVANILLIC ACID; HYDROXYTYROSOL; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; OLIVE OIL; SULFATE;

ADULT; ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG PROTEIN BINDING; DRUG PURIFICATION; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADULT; ANTIOXIDANTS; FEMALE; HUMANS; INTESTINAL ABSORPTION; LIPOPROTEINS, LDL; MALE; PHENYLETHYL ALCOHOL; PLANT OILS;

EID: 77949275742     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2009.12.016     Document Type: Article

References (41)

1. Keys A. Mediterranean diet and public health: personal reflections. Am J Clin Nutr 61 (1995) 1321-1323
2. Brenes M., Garcia A., Garcia P., Rios J.J., and Garrido A. Phenolic compounds in Spanish olive oils. J Agric Food Chem 47 (1999) 3535-3540
3. Visioli F., Bellomo G., and Galli C. Free radical-scavenging properties of olive oil polyphenols. Biochem Biophys Res Commun 247 (1998) 60-64
4. Visioli F., Caruso D., Galli C., Viappiani S., Galli G., and Sala A. Olive oils rich in natural catecholic phenols decrease isoprostane excretion in humans. Biochem Biophys Res Commun 278 (2000) 797-799
5. Visioli F., Caruso D., Grande S., Bosisio R., Villa M., Galli G., et al. Virgin Olive Oil Study (VOLOS): vasoprotective potential of extra virgin olive oil in mildly dyslipidemic patients. Eur J Nutr 6 (2004) 1-7
6. Fito M., Gimeno E., Covas M.I., Miro E., Lopez-Sabater Mdel C., Farre M., et al. Postprandial and short-term effects of dietary virgin olive oil on oxidant/antioxidant status. Lipids 37 (2002) 245-251
7. Marrugat J., Covas M.I., Fito M., Schroder H., Miro-Casas E., Gimeno E., et al. Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation-a randomized controlled trial. Eur J Nutr 43 (2004) 140-147
8. Leger C.L., Carbonneau M.A., Michel F., Mas E., Monnier L., Cristol J.P., et al. A thromboxane effect of a hydroxytyrosol-rich olive oil wastewater extract in patients with uncomplicated type I diabetes. Eur J Clin Nutr 59 (2005) 727-730
9. Petroni A., Blasevich M., Salami M., Papini N., Montedoro G.F., and Galli C. Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil. Thromb Res 78 (1995) 151-160
10. Dell'Agli M., Maschi O., Galli G.V., Fagnani R., Dal Cero E., Caruso D., et al. Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase. Br J Nutr 99 (2008) 945-951
11. Wiseman S.A., Mathot J.N., de Fouw N.J., and Tijburg L.B. Dietary non-tocopherol antioxidants present in extra virgin olive oil increase the resistance of low density lipoproteins to oxidation in rabbits. Atherosclerosis 120 (1996) 15-23
12. De La Cruz J.P., Villalobos M.A., Carmona J.A., Martin-Romero M., Smith-Agreda J.M., and de la Cuesta F.S. Antithrombotic potential of olive oil administration in rabbits with elevated cholesterol. Thromb Res 100 (2000) 305-315
13. Ochoa J.J., Quiles J.L., Ramírez-Tortosa M.C., Mataix J., and Huertas J.R. Dietary oils high in oleic acid but with different unsaponificable contents have different effects in fatty acid composition and peroxidation in rabbit LDL. Nutrition 18 (2002) 60-65
14. Aguilera C.M., Ramirez-Tortosa M.C., Mesa M.D., Ramirez-Tortosa C.L., and Gil A. Sunflower, virgin-olive and fish oils differentially affect the progression of aortic lesions in rabbits with experimental atherosclerosis. Atherosclerosis 162 (2002) 335-344
15. Visioli F., Galli C., Grande S., Colonnelli K., Patelli C., Galli G., et al. Hydroxytyrosol excretion differs between rats and humans and depends on the vehicle of administration. J Nutr 133 (2003) 1612-1615
16. Owen R.W., Mier W., Giacosa A., Hull W.E., Spiegelhalder B., and Bartsch H. Phenolic compounds and squalene in olive oils: the concentration and antioxidant potential of total phenols, simple phenols, secoiridoids, lignans and squalene. Food Chem Toxicol 38 (2000) 647-659
17. González-Santiago M., Martín-Bautista E., Carrero J.J., Fonollá J., Baró L., Bartolomé M.V., et al. One-month administration of hydroxytyrosol, a phenolic antioxidant present in olive oil, to hyperlipemic rabbits improves blood lipid profile, antioxidant status and reduces atherosclerosis development. Atherosclerosis 188 (2006) 35-42
18. Brenes M., García A., García P., Rios J.J., and Garrido A. Phenolic compounds in Spanish olive oils. J Agric Food Chem 47 (1999) 3535-3540
19. Chung B.H., Wilkinson T., Geer J.C., and Segrest J.P. Preparative and quantitative isolation of plasma lipoprotein: rapid, single, discontinuous density gradient centrifugation in a vertical rotor. J Lipid Res 21 (1980) 284-291
20. Bai C., Yan X., Takenaka M., Sekiya K., and Nagata T. Determination of synthetic hydroxytyrosol in rat plasma by GC-MS. J Agric Food Chem 46 (1998) 3998-4001
21. Miller J.N., Rice-Evans C., Davies M.J., Gopinathan V., and Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 84 (1993) 407-412
22. Fukunaga K., Yoshida M., and Nakazono N. A simple, rapid, highly sensitive and reproducible quantification method for plasma malondialdehyde by high-performance liquid chromatography. Biomed Chromatogr 12 (1998) 300-303
23. Esterbauer H., Striegl H., and Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun 6 (1989) 67-75
24. Radtke J., Linseisen J., and Wolfram G. Phenolic acid intake of adults in a Bavarian subgroup of the national food consumption survey. Z Ernahrungswiss 37 (1998) 190-197
25. Williamson G., and Holst B. Dietary reference intake (DRI) value for dietary polyphenols: are we heading in the right direction?. Br J Nutr 99 Suppl.3 (2008) S55-S58
26. Visioli F., Galli C., Bornet F., Mattei A., Patelli R., Galli C., et al. Olive oil phenolics are dose-dependently absorbed in humans. FEBS Lett 468 (2000) 159-160
27. Bonanome A., Pagnan A., Caruso D., Toia A., Xamin A., Fedeli E., et al. Evidence of postprandial absorption of olive oil phenols in humans. Nutr Metab Cardiovasc Dis 20 (2000) 111-120
28. Miro-Casas E., Covas M.I., Farre M., Fito M., Ortuno J., Weinbrenner T., et al. Hydroxytyrosol disposition in humans. Clin Chem 49 (2003) 945-952
29. Vissers M.N., Zock P.L., Roodenburg A.J., Leenen R., and Katan M.B. Olive oil phenols are absorbed in humans. J Nutr 132 (2002) 409-417
30. Miro-Casas E., Farre Albaladejo M., Covas M.I., Rodriguez J.O., Menoyo Colomer E., Lamuela Raventos R.M., et al. Capillary gas chromatography-mass spectrometry quantitative determination of hydroxytyrosol and tyrosol in human urine after olive oil intake. Anal Biochem 294 (2001) 63-72
31. Miro Casas E., Farre Albadalejo M., Covas Planells M.I., Fito Colomer M., Lamuela Raventos R.M., and de la Torre Fornell R. Tyrosol bioavailability in humans after ingestion of virgin olive oil. Clin Chem 47 (2001) 341-343
32. Caruso D., Visioli F., Patelli R., Galli C., and Galli G. Urinary excretion of olive oil phenols and their metabolites in humans. Metabolism 50 (2001) 1426-1428
33. Weinbrenner T., Fito M., Farre Albaladejo M., Saez G.T., Rijken P., Tormos C., et al. Bioavailability of phenolic compounds from olive oil and oxidative/antioxidant status at postprandial state in healthy humans. Drugs Exp Clin Res 30 (2004) 207-212
34. Covas M.I., de la Torre K., Farré-Albaladejo M., Kaikkonen J., Fitó M., López-Sabater C., et al. Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Radic Biol Med 40 (2006) 608-616
35. Tuck K.L., Freeman M.P., Hayball P.J., Stretch G.L., and Stupans I. The in vivo fate of hydroxytyrosol and tyrosol, antioxidant phenolic constituents of olive oil, after intravenous and oral dosing of labeled compounds to rats. J Nutr 131 (2001) 1993-1996
36. D'Angelo S., Manna C., Migliardi V., Mazzoni O., Morrica P., Capasso G., et al. Pharmacokinetics and metabolism of hydroxytyrosol, a natural antioxidant from olive oil. Drug Metab Dispos 29 (2001) 1492-1498
37. Ragione F.D., Cucciolla V., Borriello A., Pietra V.D., Pontoni G., Racioppi L., et al. Hydroxytyrosol, a natural molecule occurring in olive oil, induces cytochrome c-dependent apoptosis. Biochem Biophys Res Commun 278 (2000) 733-739
38. Gimeno E., Fito M., Lamuela-Raventos R.M., Castellote A.I., Covas M., Farre M., et al. Effect of ingestion of virgin olive oil on human low-density lipoprotein composition. Eur J Clin Nutr 56 (2002) 114-120
39. Lamuela-Raventos R.M., Gimeno E., Fito M., Castellote A.I., Covas M., de la Torre-Boronat M.C., et al. Interaction of olive oil phenol antioxidant components with low-density lipoprotein. Biol Res 37 (2004) 247-252
40. de la Torre-Carbot K., Chávez-Servín J.L., Jaúregui O., Castellote A.I., Lamuela-Raventós R.M., Fitó M., et al. Presence of virgin olive oil phenolic metabolites in human low density lipoprotein fraction: determination by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. Anal Chim Acta 583 (2007) 402-410
41. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241